INTRODUCTION
While the primary goal of HIV therapy today in developed countries is to delay disease progression through suppressing viral load with medications, healthcare providers are challenged to assist HIV-infected persons with efforts to maintain an optimal state of health and quality of life through effective symptom management. Symptom management for persons with HIV disease includes the prevention, assessment and treatment of symptoms. The focus of symptom management in HIV comprises the interacting symptom clusters which result from the HIV infection, associated opportunistic infections and malignancies, and the side-effects from prophylactic and therapeutic interventions (Ropka 1994) . The recent advent of highly active antiretroviral therapy (HAART) has been accompanied by reports of therapy intolerance due to treatment-related symptoms (Berrey et al. 1998 , Melbourne et al. 1998 . In this article, the authors report on the development and validation of the Sign and Symptom Check-List for Persons with HIV Disease (SSC-HIV), a tool designed for symptom assessment in HIV/AIDS.
REVIEW OF THE LITERATURE Signi®cance
The importance of symptom assessment and management in HIV/AIDS has been documented in a number of investigations including Hurley & Ungvarski's (1994) study of problems of HIV/AIDS clients in home care, Smith & Rapkin's (1995) study of unmet needs for help among persons with AIDS and Janson-Bjerklie et al. 's (1992) examination of pulmonary problems experienced by patients hospitalized for Pneumocystis carinii pneumonia. Based upon the care plans of a sample of hospitalized AIDS patients, Henry et al. (1994) reported that the top ®ve signs and symptoms included: dyspnoea (51%), fever (41%), fatigue (18%), nutrition problems (17%) and medication side-effects (10%). Holzemer et al. (1995) described the manner in which patient problems changed over time in a sample of hospitalized AIDS patients. The largest number of problems were reported in two clusters, symptoms related to disease including shortness of breath, fever and fatigue, as well as symptoms related to treatment including nausea and vomiting.
More recently, Melbourne et al. (1998) , in a retrospective analysis of 74 HIV-infected patients for whom ritonavir was prescribed, found that the primary reason for discontinuation among 32 patients was intolerance (81%). Symptoms for the intolerant group vs. the tolerant group were as follows: nausea, 73% vs. 30%; vomiting, 50% vs. 14%; and diarrhoea, 46% vs. 54%. High symptomatology has also been reported in health care workers treated with postexposure prophylaxis (PEP): nausea (59%), vomiting (18%), headache (18%), diarrhoea (17%), and myalgias or arthralgias (8%) (Wang et al. 1998 ). The ®ndings from these studies provide evidence that both pre-and post-HAART the experience of living with HIV infection is multifaceted and extends beyond the traditional de®nition of singular signs and symptoms as indicators of disease progression.
Several investigators have noted that one of nursing's signi®cant contributions to the care of individuals living with HIV disease is in the area of symptom management (Zeller et al. 1993 , Gebbie 1995 . Furthermore, in her comprehensive review of the literature on patient care outcomes related to management of symptoms Hegyvary (1993 p. 162) concluded that`Outcomes research related to W.L. Holzemer et al. symptom management is an essential adjunct to outcomes research related to mechanisms and treatment of disease.' Wilson & Cleary (1995 p. 61) , in their multidimensional model of health-related quality of life, de®ned a symptom as`a patient's perception of an abnormal physical, emotional, or cognitive state'. Hegyvary (1993 p. 146) de®ned symptoms as`the perceived indicators of change in normal functioning as experienced by patients'. Congruent with these de®nitions, the conceptual model of symptom management published by the University of California San Francisco School of Nursing Symptom Management Faculty Group (1994) de®nes symptoms as subjective experiences re¯ecting changes in a person's biopsychosocial function, sensation or cognition. The model acknowledges the relationship between signs (detectable by another person and sometimes the patient) and symptoms, noting that both signs and symptoms bring the attention of a patient or healthcare provider to a problem. The model includes three interrelated dimensions: (1) symptom experience (symptom perception, symptom evaluation, symptom response); (2) symptom management strategies provided by patient, family, healthcare providers and the healthcare system; and (3) symptom outcomes (e.g. functional status, quality of life, self-care ability, mortality). The focus of this article is on the measurement of the ®rst dimension, the symptom experience.
De®nitions

Measurement of symptom status in HIV/AIDS
Instruments used for symptom assessment in HIV/AIDS research generally fall into one of three categories: (1) Schag et al. 1992) . Only one symptom assessment scale was located that focused speci®cally on symptoms related to HIV/AIDS, the HIV Assessment Tool (HAT) (Nokes et al. 1994) , and some subjects have reported dif®culty completing the instrument (Nokes, personal communication) .
Correlates of symptoms
Numerous studies have documented the impact of symptoms upon the quality of life for people living with HIV disease. Valente et al. (1993) reported that the number of HIV symptoms experienced was positively correlated with both depression and change towards unhealthy self-care behaviours. Linn et al. (1993) stressed the importance of perceived physical symptoms for psychological functioning among HIV-infected adults. Several investigations have linked gastrointestinal symptoms with quality of life. Mazonson et al. (1992) reported a signi®cant relationship between chronic diarrhoea and decreasing quality of life. Grosvenor et al. (1989) reported that relief from gastrointestinal symptoms was more important to quality of life in patients with advanced HIV infection than was pain control. Ragsdale & Morrow (1990) examined symptoms and quality of life in HIV + persons using the Sickness Impact Pro®le and the Symptom Distress Scale and con®rmed the ®ndings of Lubeck & Fries (1993) that higher symptom scores were related to lower quality of life scores. Wachtel et al. (1992) reported that in a sample of HIVinfected patients, 72% of the patients reported neurological symptoms (memory dif®culties, seizures, weakness or numbness), 69% reported constitutional symptoms (fever, chills, night sweats, weight loss), 50% reported dyspnoea, and 47% reported diarrhoea. The presence of multiple symptoms was associated with a lower quality of life.
The impact of relationship between symptoms and quality of life that is supported in pre-HAART investigations, is also documented in recent studies. Shively et al. (1998) reported that increased symptom frequency and discomfort were signi®cantly related to worse health status, greater interference with social activities, greater number of days spent in bed, and greater impact of illness or treatment on health status. In a sample of 42 HIVinfected women, of whom 68% were African American, greater total number of HIV symptoms was associated with decreased quality of life related to role function, health distress, health transition and mental health as measured by the MOS-HIV (Israelski et al. 1998 ).
Comparisons of nurse and patient ratings of symptoms
Nurses' ratings have been shown to consistently underestimate the frequency and intensity of the signs and symptoms experienced by patients with HIV disease , Reilly et al. 1997 . These ®ndings support the consensus in the symptom management literature that the patient is the`gold' standard for understanding the symptom experience.
These studies have reported a variety of methods and sampled people at different points in the unfolding course of their HIV illness. The overriding conclusion from these studies is that quality of life decreases as the severity of the HIV symptoms increases and the meaning of living with this symptom experience can only be captured from the patient's perspective. These studies highlight the importance of establishing sound psychometric properties of symptom assessment scales so that such scales can provide valid and reliable information about the experience of HIV symptomatology from the patient's perspective. In addition, the literature reviewed documents the lack of a symptom assessment scale that measures the broad range of HIV-related symptoms and that can be easily completed by patients across stages of illness.
METHODS
Research questions
The purpose of this investigation was to assess the validity and reliability of the Sign and Symptom Check-List for Persons with HIV Disease (SSC-HIV). Data from two samples, referred to as study 1 and study 2, are reported.
The study 1 questions were: (1) What is the factor structure (construct validity) of the instrument? (2) Are the obtained factors reliable? (3) Are there any meaningful relationships between the factor scores and demographic variables or type of care setting? (4) Is there any evidence to support the concurrent validity of the scale? (5) Are the factor scores sensitive to change over time? Study 2 questions were: (6) Will the factor structure obtained from study 1 replicate in a sample of HIV + individuals from ambulatory settings post-HAART therapy? (7) What are the reliability estimates of the obtained factors from study 2?
Design
Study 1
The primary data collected for study 1 were descriptive, cross-sectional, and examined patient data collected at one point in time close to admission to service in the hospital, skilled nursing facility and home care settings. A subset of the data was also analysed using a repeated measures design to examine changes in scores over three points in time. The repeated measures points in time for those hospitalized were admission, mid-point of hospitalization, and discharge. For participants in the skilled nursing facility and home care settings, the second and third data collection points occurred 1 and 2 weeks, respectively, after admission to the study.
Study 2
The design for study 2 was descriptive and cross-sectional.
Sample
Study 1
A convenience sample (n 247) for study 1 was obtained from three area hospitals (58á6%; n 145), one home care agency (26á1%; n 64) and one skilled nursing care facility (15á3%; n 38) during 1994±1996. A subset of 92 patients comprised the sample for the repeated measures design. Participants had a mean age of 39á3 years (SD SD 8á7) and 88% (n 217) were male. The chart audit revealed that they had an average of 76 CD4 count (SD SD 100) and were known HIV + for an average of 57 months (SD SD 37 months). The ethnicity of the 249 participants was: 52á6% (n 130) Caucasian, 21á7% (n 54) African American, 18á1% (n 45) Latino, 5á6% (n 14) Asian/ Paci®c Islander, and 2% (n 5) American Indian. Twentytwo per cent (n 54) of the participants died during the 6-month follow-up period.
Study 2
Data collection occurred during 1997±1998 in seven cities across the United States: Birmingham, Boston, Honolulu, New York, San Francisco Bay area, Seattle and Tampa. Speci®c sites within these cities varied and included university-based AIDS clinics, private practices, public and for-pro®t hospitals, residential and day care facilities, community-based organizations and home care. The sample of 686 HIV/AIDS patients had a mean age of 39á4 years (range 20±64 years), were 22á8% female, and were 43á2% White, not Hispanic. They reported knowing they were HIV + for an average of 7á41 years (1±25 years). The average CD4 count of the sample was 323 mm 3 (range 1±1500) and 61á3% had been given an AIDS diagnosis.
Human subjects
The studies were approved by each respective institutional Committee on the Protection of Human Subjects and the review boards of all participating sites.
Instruments
Study instruments included the newly constructed instrument (SSC-HIV) as well as instruments used for examination of the construct and concurrent validity. Each is described in the following section.
Sign and Symptom Check-List for Persons with HIV Disease (SSC-HIV)
Initially, 41 signs and symptoms were identi®ed that formed the original version of the scale. Each sign or symptom is rated by the participant on a three-point Likert scale as mild, moderate or severe. Participants are asked to rate the symptoms as they are experiencing them`today'. If a participant is not experiencing the symptom on the day of the assessment, they are instructed to leave the item blank. Each item is scored as blank 0, mild 1, moderate 2 and severe 3. The items within a factor are summed for a scale score.
Chart audit (study 1)
With permission of the participant, chart audits were conducted to gather demographic data, disease status (CD4 count) and mortality at 6 months. Patients selfreported months known HIV positive.
Health Status Questionnaire (HSQ) (study 1)
The 30-item HSQ (Wu et al. 1990 ) includes 20 items from the Medical Outcomes Study Ð Short Form 20 (Stewart et al. 1988 ) plus measures of energy/fatigue, cognitive functioning, health distress and quality of life. Alpha reliability estimates in this sample for the scales were: cognitive function, alpha 0á84; energy/fatigue, alpha 0á78; health distress, alpha 0á91; mental health, alpha 0á86; physical function, alpha 0á86; and role functioning alpha 0á50. Single item factors include quality of life, body pain, health transition, overall health and social function. The HSQ was collected only on hospitalized patients (n 144) for two reasons. First, a pilot study in the non-hospital samples revealed a¯oor effect in subject responses. Second, the length of time to complete the instrument was determined to be too great for the respondents in the home care and skilled nursing facility settings.
Quality Audit Marker (QAM) (study 1)
The QAM is a 10-item, nurse-completed scale designed to measure self-care ability (six items), ambulation (two items) and psychological distress (two items). Adequate validity and reliability have been reported for the scale (Holzemer et al. 1993 ). Higher scores equal greater selfcare ability, greater ambulation and less psychological distress. Reliability alphas in this sample were: self-care, alpha 0á89; ambulation, alpha 0á88; and psychological distress, alpha 0á89.
Demographic survey (study 2)
Participants completed a brief demographic survey.
Analysis
Instruments were scored and descriptive statistics calculated. For study 1, an exploratory principal components factor analysis with varimax rotation was conducted. Appropriate comparisons (e.g. chi-square, t-tests and F-tests) were made between factor scores and demographic variables.
Step-wise multiple regression analyses were performed with the obtained symptom clusters predicting a set of dependent variables to explore concurrent validity. A ®nal analysis explored the sensitivity of the symptom scores to change over time using repeated measures analyses of variances in a subset of participants (n 92) for whom longitudinal data were available. For study 2, a con®rmatory factor analysis was conducted and revised scale reliability estimates were calculated.
RESULTS
Study 1
The presentation of the results is organized according to psychometric properties in the following order: content validity, construct validity, reliability, concurrent validity and sensitivity to change.
Content validity
The content validity of the SSC-HIV was supported in several ways. First, the initial selection of items for inclusion on the scale was based upon a review of the HIV/AIDS literature and nursing care plans. The items were then reviewed by six clinicians working in direct HIV/AIDS patient care as well as two experts in HIV/AIDS complementary therapies.
Construct validity
Construct validity of the SSC-HIV was explored using principal components factor analysis with varimax rotation which resulted in an eight-factor solution that explained 67á7% of the variance. Twenty-six of the 41 original items were retained based upon the factor analysis. The symptom clusters (factors), the number of items and Cronbach alpha reliability estimates were: fever (four items, alpha 0á80); fatigue (four items, alpha 0á78); confusion (three items, alpha 0á82); nausea/vomiting (three items, alpha 0á74); psychological distress (three items, alpha 0á76); shortness of breath (three items, alpha 0á75); gastrointestinal discomfort (four items, alpha 0á72); and, diarrhoea (two items, alpha 0á76).
The construct validity of the obtained factors was further explored using the concept of known-group differences. Construct validity is supported if one observes differences between groups as expected. The authors hypothesized that there would be no differences in symptom factor scores by demographic variables or type of setting. Appropriate tests of comparisons were run between the demographic variables (age, gender, ethnicity) and type of setting with the symptom factor scores as the dependent variables. No signi®cant differences were found.
Reliability of factors
The Cronbach alpha reliability estimates of internal consistency ranged from 0á72 to 0á82 for the factor scores.
Concurrent validity
Step-wise multiple regressions were calculated with each of the 11 HSQ scores as dependent variables and the eight SSC-HIV factor scores as predictors. The authors generated hypotheses about the potential relationships between the SSC-HIV factor scores and the HSQ scores. Hypotheses and results are presented simultaneously to facilitate interpretation of the ®ndings. The sample for these analyses was limited to the 144 hospitalized patients who completed the HSQ.
· H1: Fever would be signi®cantly related to energy/ fatigue. Results: not signi®cant. · H2: Fatigue would be signi®cantly related to energy/ fatigue. Results: not signi®cant. · H3: Confusion would be signi®cantly related to cognitive function. Results: 27% of the variance in cognitive function was explained by confusion. · H4: Nausea/vomiting would be signi®cantly related to health distress and quality of life. Results: not signi®-cant. · H5: Psychological distress would be signi®cantly related to general health perception, health transition and mental health. Results: partially supported. Psychological distress explained 34% of the variance in mental health and 23% in health transition; it was not signi®cantly related to general health perceptions. An unexpected ®nding was that it explained an additional 7% of the variance in energy/fatigue. · H6: Shortness of breath (SOB) would be signi®cantly related to general health perception, role functioning and social functioning. Results: partially supported. SOB explained 19% of the variance in general health perception and 8% of the variance in social functioning. It was not related to role functioning. · H7: Diarrhoea would be signi®cantly related to energy/ fatigue, health distress and quality of life. Results: partially supported. Diarrhoea explained 33% of the variance in energy/fatigue and 25% in health distress. Diarrhoea was not related to quality of life.
The concurrent validity of the HIV-SSC was also examined by comparing HIV-SSC factor scores with the three scales of the QAM. Patients' ratings of fever explained 15% of the nurses' ratings of self-care ability. Patients' ratings of psychological distress explained 18% of the nurses ratings of ambulation, but were not related to the nurses' ratings of the patients' psychological distress. Patients' ratings of nausea/vomiting explained 13% of the nurses' ratings of psychological distress.
Sensitivity to change
Eight separate one (group) by three (points in time) repeated measures analyses of variance (ANOVA ANOVA) demonstrated that the eight symptom factor scores signi®cantly decreased over time. The participants reported fewer symptoms at Time 3 than at admission (Time 1).
Study 2
A con®rmatory factor analysis was performed with the new sample, collected after widespread adoption of HAART therapy (see Table 1 ). The obtained factor solution was complementary, but slightly altered from the initial solution obtained in study 1. Three changes in the solution were noted. First, the items dry mouth and thirst moved from the gastrointestinal factor to the malaise/ fatigue/weakness factor. Second, the remaining gastrointestinal items (gas/bloating and abdominal pain) merged with the diarrhoea factor (loose stools and diarrhoea); this appeared valid from a clinical perspective. Third, the initial factors of confusion and psychological distress merged into the revised factor named confusion/distress. This revised total solution was more parsimonious (six factors instead of eight) and retained strong Cronbach alpha reliability coef®cients for the six factor scales and the total score. For these reasons, the authors propose utilizing the factor structure as presented in Table 1 for scoring the SSC-HIV scale.
DISCUSSION
The factor analyses provide strong evidence for the construct validity and internal consistency reliability of the 26-item SSC-HIV. Study 1 provided modest support for the concurrent validity of the SSC-HIV symptom factor scores with the HSQ factors, with total variance explained ranging from 0á19 to 0á40. One possible explanation for the strength of the relationships not being greater is that the HSQ measures more global concepts (e.g. general health perception) which are in¯uenced by many factors, whereas the SSC-HIV measures speci®c symptom clusters. In addition, the temporal context for the patients' self-report is different for the two instruments. The ratings on the SSC-HIV refer to`today' and the context for ratings on the HSQ is`within the last 4 weeks'. The analyses assessing the relationship between the patient-completed SSC-HIV and the nurse-completed QAM provide little support for concurrent validity. Of particular note is the fact that the patients' ratings of psychological distress on the SSC-HIV were not related to the nurses' ratings of psychological distress on the QAM. There are at least two plausible explanations for this. First, the psychological distress factor score on the SSC-HIV includes depression which is not included in the QAM psychological distress factor score. Second, numerous studies (e.g. Reilly et al. 1997) have noted the discrepancy between patient and nurse ratings of symptoms. The repeated measures ANOVA ANOVAs strongly support the sensitivity of the scale to detect change in clinical status over time.
The study 2 solution is more parsimonious with its six factors and this solution actually improved the reliability estimates. The SSC-HIV is available to utilize in studies related to assessment of the sign and symptom experience for people living with HIV disease (Appendix 1). The ®ndings of studies 1 and 2 suggest that the SSC-HIV has utility for clinical care across settings. Researchers may wish to use the 26-item SSC-HIV because of the evidence supporting its validity and reliability. However, it may also be appropriate to include other symptoms that did not cluster in these analyses for purposes of describing the symptom experience of persons living with HIV/AIDS.
There are a number of limitations to the SSC-HIV. First, one can not distinguish between missing data and items purposefully left blank. Second, the SSC-HIV does not include any symptoms unique to women's experience of living with HIV/AIDS. Future work needs to address these limitations.
Although HAART may impact the symptom experience for some, symptom management remains a major component of HIV/AIDS care. Routine incorporation of symptom assessment into the care process has the potential to improve the communication between patient and healthcare provider as well as to facilitate the initiation of interventions targeted at a particular symptom cluster. Additional studies are needed that focus on the impact of routine symptom assessment on process of care variables (e.g. patient-healthcare provider communication, selection of symptom management strategies) and symptom management outcomes (e.g. functional status, self-care ability, emotional status, health service utilization, mortality, morbidity and comorbidity, quality of life). The clinical trajectory of HIV disease is now that of a chronic illness. Given that the relationship between symptom status and quality of life has been demonstrated in a number of investigations the inclusion of a reliable and valid symptom assessment tool such as the SSC-HIV is a signi®cant part of an overall symptom management strategy.
